The Enhanced Games — tech’s steroid extravaganza — didn’t pay off, as company posts $60 million loss
- ID
- 16238
- Status
- summarized
- Published
- 21 Aug 2026, 5:08 AM
- Fetched
- 21 Aug 2026, 6:04 AM
- Provider
- TechCrunch
- Category
- technology
- Original URL
- https://techcrunch.com/2026/08/20/the-enhanced-games-techs-steroid-extravaganza-didnt-pay-off-as-company-posts-60-million-loss/
- Source URL
- https://techcrunch.com/feed/
Summary
- Score
- 2.5
- Created
- 21 Aug 2026, 6:07 AM
- Tags
- Audience
- saas_founders
What happened
The Enhanced Group, a telehealth company that IPO'd at a $1.2 billion valuation, posted a $62 million net loss in Q2 after hosting the 'Enhanced Games'—a competition allowing performance-enhancing drugs. Only $17.7 million in revenue came in, mostly from event sponsorships rather than its core telehealth business, casting doubt on whether the games will recur annually.
Why it matters
A cautionary tale for founders tempted to burn capital on a flashy marketing spectacle: the games cost tens of millions and didn't translate into meaningful core-business revenue, with scant evidence the telehealth platform itself grew. If you're evaluating event-driven growth strategies, this is a concrete data point on how badly they can misfire.
Discussion angle
When does a brand-building spectacle become a distraction from the core product—and how do you set a kill threshold before you're $60M in the hole?